Wickstrom K (2008) Acute bacterial conjunctivitis - benefits versus risks with antibiotic treatment. Acta Ophthalmol (Oxf.) 86: 2-4.Wickström K ( 2008 ): Acute bacterial conjunctivitis – benefits versus risks with antibiotic treatment . Acta Ophthalmol 86 : 2 – 4 ....
INTRODUCTION: Most cases of conjunctivitis in adults are probably due to viral infection, but children are more likely to develop bacterial conjunctivitis than they are viral forms. The main bacterial pathogens are Haemophilus influenzae and Streptococcus pneumoniae in adults and children, and Moraxella ...
2) bacterial conjunctivitis 细菌性结膜炎 1. Effects of gel gatifloxacin versus levofloxacin in treatment ofbacterial conjunctivitis; 加替沙星与左氧氟沙星眼用凝胶对细菌性结膜炎的疗效比较 2. A randomized double-blind control clinical study on levofloxacin eye drops forbacterial conjunctivitisand keratitis;...
3‐day treatment with azithromycin 1.5% eye drops versus 7‐day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children主要由Cochereau, Isabelle、Meddeb‐Ouertani, Amel、Kh
Examination variables included axillary temperature, respiratory rate, whether the child “appeared well” (normal breathing, alert, active, normal muscle tone) and whether there was evidence of a focal infection (upper respiratory tract infection, conjunctivitis, soft tissue infection, bone/joint ...
The effects of certain systemic viral and bacterial infections on morbidity and mortality are considered as examples of recent emerging infections. Here we will focus on three examples of infections that are important in pregnancy and early childhood: SARS-CoV-2 virus, Zika virus, and Mycoplasma ...
(2008) Acute bacterial conjunctivitis—benefits versus risks with antibiotic treatment. Acta. Ophthalmol. (Oxf). 86: pp. 2-4Wickstrom K. Acute bacterial conjunctivitis--benefits versus risks with antibiotic treatment. Acta Ophthalmol. 2008;86(1):2-4....
N. OrzalesiP. VelatiE. BujtarF. PonteS. DamianiM.G. BucciOphthalmologicaet al. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: a multicenter double-blind phase III study. Ophthalmologica - PE, Lobefalo, et al....
Antibiotics versus placebo for acute bacterial conjunctivitis (Cochrane Review). The Cochrane Library Issue 1, 2002. Oxford: Update Software.Sheikh A, Hurwitz B. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2006;2:CD001211....
P 127 FML-gentamicin versus FML-neomycin in the treatment of bacterial conjunctivitisdoi:10.1016/0042-6989(95)98651-OP. HuguetA. JauchVision Research